Overview

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

Status:
Not yet recruiting

Trial end date:
2024-08-14

Target enrollment:

Participant gender:

Summary

The aim of the study is to determine if triptorelin formulated for use every 6 months (given twice during the study) is effective and safe for when given by injection under the skin for the treatment of adult males with cancer in the prostate.

Phase:

Phase 3

Details

Lead Sponsor:

Ipsen

Treatments:

Triptorelin Pamoate